These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 18759537)
1. Value of oligoclonal band study in clinically isolated syndromes and multiple sclerosis. Alvarez-Cermeño JC; Gasalla T; Villar LM Expert Rev Neurother; 2008 Sep; 8(9):1279-80. PubMed ID: 18759537 [No Abstract] [Full Text] [Related]
2. Multiple sclerosis with uncommon cerebrospinal fluid findings. Rot U; Mesec A; Pogacnik T Croat Med J; 2003 Dec; 44(6):697-701. PubMed ID: 14652881 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. Thompson EJ; Freedman MS Adv Neurol; 2006; 98():147-60. PubMed ID: 16400832 [No Abstract] [Full Text] [Related]
4. Role of MRI criteria and OB for diagnosing multiple sclerosis in patients presenting with clinically isolated syndromes. Tintore M; Sastre-Garriga J Mult Scler; 2009 Apr; 15(4):407-8. PubMed ID: 19324977 [No Abstract] [Full Text] [Related]
5. The specificity of oligoclonal bands in multiple sclerosis. Lipton HL Ann Neurol; 2009 Jun; 65(6):621-2. PubMed ID: 19557872 [No Abstract] [Full Text] [Related]
7. CSF analysis in suspected MS: do bands aid? Hintzen RQ; Giovannoni G Neurology; 2008 Mar; 70(13 Pt 2):1059-60. PubMed ID: 18362264 [No Abstract] [Full Text] [Related]
8. [Multiple sclerosis and oligoclonal IgG bands]. Nakashima I; Fujihara K; Fujimori J; Misu T; Itoyama Y No To Shinkei; 2004 Jun; 56(6):475-82. PubMed ID: 15328836 [No Abstract] [Full Text] [Related]
9. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Imrell K; Landtblom AM; Hillert J; Masterman T Neurology; 2006 Sep; 67(6):1062-4. PubMed ID: 17000979 [TBL] [Abstract][Full Text] [Related]
10. Oligoclonal bands in tears. Lolli F; Franciotta D Mult Scler; 2010 Jun; 16(6):760; author reply 761. PubMed ID: 20558504 [No Abstract] [Full Text] [Related]
11. Oligoclonal bands measured in unconcentrated cerebrospinal fluid and other biochemical parameters in multiple sclerosis. Kurzepa J; Nastaj M; Mitosek-Szewczyk K; Bartosik-Psujek H; Stelmasiak Z Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):392-6. PubMed ID: 16146115 [TBL] [Abstract][Full Text] [Related]
12. 10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous system. Mehling M; Kuhle J; Regeniter A Neurologist; 2008 Jan; 14(1):60-5. PubMed ID: 18195662 [No Abstract] [Full Text] [Related]
13. [Oligoclonal bands in multiple sclerosis: clinical significance and diagnostic usefulness]. La Mantia L; Nespolo A; Tajoli L; Cerrato D; Milanese C; Corridori F Riv Neurobiol; 1982; 28(1-2):154-61. PubMed ID: 7185119 [No Abstract] [Full Text] [Related]
14. The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis. Zipoli V; Hakiki B; Portaccio E; Lolli F; Siracusa G; Giannini M; Pantoni L; Pescini F; Sorbi S; Amato MP Mult Scler; 2009 Apr; 15(4):472-8. PubMed ID: 19153171 [TBL] [Abstract][Full Text] [Related]
16. Optimizing detection of oligoclonal bands in cerebrospinal fluid by use of isoelectric focusing with IgG immunoblotting. Keren DF Am J Clin Pathol; 2003 Nov; 120(5):649-51. PubMed ID: 14608888 [No Abstract] [Full Text] [Related]
17. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Obermeier B; Mentele R; Malotka J; Kellermann J; Kümpfel T; Wekerle H; Lottspeich F; Hohlfeld R; Dornmair K Nat Med; 2008 Jun; 14(6):688-93. PubMed ID: 18488038 [TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging demonstration of fascicular inflammation in sixth nerve palsy as the presenting symptom in multiple sclerosis. Szabo K; Kern R; Griebe M; Baezner H; Hennerici MG; Gass A Eur Neurol; 2008; 60(2):92-4. PubMed ID: 18552495 [No Abstract] [Full Text] [Related]
19. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds. Idiman E; Ozakbas S; Dogan Y; Kosehasanogullari G J Neuroimmunol; 2009 Jul; 212(1-2):121-4. PubMed ID: 19457560 [TBL] [Abstract][Full Text] [Related]